• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506.神经退行性疾病动物模型中的钙差异变化:FK506的逆转作用
Neuroscience. 2015 Dec 3;310:549-60. doi: 10.1016/j.neuroscience.2015.08.068. Epub 2015 Sep 2.
2
Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism.在帕金森病的MPTP模型中,α-突触核蛋白诱导Tau蛋白的过度磷酸化。
FASEB J. 2006 Nov;20(13):2302-12. doi: 10.1096/fj.06-6092com.
3
Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1.在表达突变型β-淀粉样前体蛋白和早老素-1的双转基因小鼠中磷酸化α-突触核蛋白的积累增强。
J Neurosci Res. 2007 Aug 1;85(10):2246-52. doi: 10.1002/jnr.21352.
4
Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?具有神经保护活性的β-突触核蛋白衍生肽:神经退行性疾病的一种替代治疗方法?
J Mol Neurosci. 2004;24(1):155-65. doi: 10.1385/JMN:24:1:155.
5
Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.通过 RNA 干扰减少海马体 α-突触核蛋白可改善阿尔茨海默病小鼠的神经病理学。
J Alzheimers Dis. 2023;95(1):349-361. doi: 10.3233/JAD-230232.
6
Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies.海马神经元细胞中积累的α-突触核蛋白片段更容易受到 mGluR5 介导的 Aβ寡聚体毒性的影响——这与路易体痴呆有关。
Mol Neurodegener. 2014 May 19;9:18. doi: 10.1186/1750-1326-9-18.
7
Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.减少内源性α-突触核蛋白可减轻阿尔茨海默病转基因小鼠模型中特定神经元群体的退化。
J Neurosci. 2016 Jul 27;36(30):7971-84. doi: 10.1523/JNEUROSCI.0775-16.2016.
8
TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau.TRIM28调节α-突触核蛋白和tau蛋白的核内积累及其毒性。
Elife. 2016 Oct 25;5:e19809. doi: 10.7554/eLife.19809.
9
Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.将野生型人 tau 引入 APP 转基因小鼠中形成神经原纤维缠结。
Acta Neuropathol. 2014 May;127(5):685-98. doi: 10.1007/s00401-014-1259-1. Epub 2014 Feb 15.
10
Influence of Lentiviral β-Synuclein Overexpression in the Hippocampus of a Transgenic Mouse Model of Alzheimer's Disease on Amyloid Precursor Protein Metabolism and Pathology.慢病毒介导的β-突触核蛋白在阿尔茨海默病转基因小鼠模型海马中过表达对淀粉样前体蛋白代谢及病理的影响
Neurodegener Dis. 2015;15(4):243-57. doi: 10.1159/000430952. Epub 2015 Jun 25.

引用本文的文献

1
Microprism-based two-photon imaging of the mouse inferior colliculus reveals novel organizational principles of the auditory midbrain.基于微棱镜的小鼠下丘双光子成像揭示了听觉中脑的新组织原则。
Elife. 2025 Mar 14;12:RP93063. doi: 10.7554/eLife.93063.
2
Evaluating chemical effects on human neural cells through calcium imaging and deep learning.通过钙成像和深度学习评估化学物质对人类神经细胞的影响。
iScience. 2024 Nov 1;27(12):111298. doi: 10.1016/j.isci.2024.111298. eCollection 2024 Dec 20.
3
Harnessing IGF-1 and IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in α-synucleinopathies.利用胰岛素样生长因子-1(IGF-1)和白细胞介素-2(IL-2)作为钙调神经磷酸酶活性的生物标志物,为α-突触核蛋白病量身定制最佳的FK506剂量。
Front Mol Biosci. 2023 Nov 29;10:1292555. doi: 10.3389/fmolb.2023.1292555. eCollection 2023.
4
Targeting CaN/NFAT in Alzheimer's brain degeneration.靶向阿尔茨海默病大脑退化中的 CaN/NFAT。
Front Immunol. 2023 Nov 23;14:1281882. doi: 10.3389/fimmu.2023.1281882. eCollection 2023.
5
Melatonin inhibits Japanese encephalitis virus replication and neurotoxicity via calcineurin-autophagy pathways.褪黑素通过钙调神经磷酸酶自噬途径抑制日本脑炎病毒复制和神经毒性。
BMC Neurosci. 2023 Nov 6;24(1):59. doi: 10.1186/s12868-023-00832-1.
6
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.一种用于测试帕金森病新疗法的小鼠模型:Thy1-aSyn(“line 61”)小鼠的最新研究进展。
Neurotherapeutics. 2023 Jan;20(1):97-116. doi: 10.1007/s13311-022-01338-0. Epub 2023 Jan 30.
7
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly.靶向 tau 仅细胞外可能不如靶向细胞内外都更有效。
Semin Cell Dev Biol. 2022 Jun;126:125-137. doi: 10.1016/j.semcdb.2021.12.002. Epub 2021 Dec 9.
8
Increased neuronal activity in motor cortex reveals prominent calcium dyshomeostasis in tauopathy mice.运动皮层神经元活动增加揭示了tau 病小鼠中明显的钙代谢失衡。
Neurobiol Dis. 2021 Jan;147:105165. doi: 10.1016/j.nbd.2020.105165. Epub 2020 Nov 6.
9
Electrophysiological and Imaging Calcium Biomarkers of Aging in Male and Female 5×FAD Mice.衰老的雄性和雌性 5×FAD 小鼠的电生理和影像学钙生物标志物。
J Alzheimers Dis. 2020;78(4):1419-1438. doi: 10.3233/JAD-200109.
10
Chronic α-Synuclein Accumulation in Rat Hippocampus Induces Lewy Bodies Formation and Specific Cognitive Impairments.慢性α-突触核蛋白在大鼠海马中的积累诱导路易体形成和特定认知障碍。
eNeuro. 2020 Jun 15;7(3). doi: 10.1523/ENEURO.0009-20.2020. Print 2020 May/Jun.

本文引用的文献

1
A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.一种新型的三重复突变tau转基因模型,可模拟皮克病和额颞叶tau蛋白病的某些方面。
PLoS One. 2015 Mar 24;10(3):e0121570. doi: 10.1371/journal.pone.0121570. eCollection 2015.
2
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.α-突触核蛋白寡聚倾向的积累加剧体内突触和神经元的退化。
Brain. 2014 May;137(Pt 5):1496-513. doi: 10.1093/brain/awu057. Epub 2014 Mar 24.
3
Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo.携带神经原纤维缠结的神经元在体内的皮质回路中具有功能性整合。
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):510-4. doi: 10.1073/pnas.1318807111. Epub 2013 Dec 24.
4
In vivo alterations in calcium buffering capacity in transgenic mouse model of synucleinopathy.在帕金森病相关联蛋白转基因小鼠模型中钙缓冲能力的体内改变。
J Neurosci. 2012 Jul 18;32(29):9992-8. doi: 10.1523/JNEUROSCI.1270-12.2012.
5
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease.可溶性淀粉样蛋白-β在阿尔茨海默病小鼠模型中海马早期过度兴奋中的关键作用。
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8740-5. doi: 10.1073/pnas.1206171109. Epub 2012 May 16.
6
Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.阿尔茨海默病中的异常tau、线粒体功能障碍、线粒体轴突运输受损和突触缺失。
Brain Res. 2011 Sep 30;1415:136-48. doi: 10.1016/j.brainres.2011.07.052. Epub 2011 Jul 31.
7
Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection.钙失调和神经钙的动态平衡在神经退行性疾病的分子机制中为神经保护提供了多个靶点。
Antioxid Redox Signal. 2011 Apr 1;14(7):1275-88. doi: 10.1089/ars.2010.3359. Epub 2010 Oct 6.
8
Automated analysis of cellular signals from large-scale calcium imaging data.对大规模钙成像数据中的细胞信号进行自动分析。
Neuron. 2009 Sep 24;63(6):747-60. doi: 10.1016/j.neuron.2009.08.009.
9
Calcium signaling and neurodegenerative diseases.钙信号传导与神经退行性疾病
Trends Mol Med. 2009 Mar;15(3):89-100. doi: 10.1016/j.molmed.2009.01.001. Epub 2009 Feb 21.
10
Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.在阿尔茨海默病小鼠模型中,淀粉样斑块附近的高活性神经元簇。
Science. 2008 Sep 19;321(5896):1686-9. doi: 10.1126/science.1162844.

神经退行性疾病动物模型中的钙差异变化:FK506的逆转作用

Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506.

作者信息

Overk C R, Rockenstein E, Florio J, Cheng Q, Masliah E

机构信息

Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, United States.

Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, United States; Department of Pathology, University of California, San Diego, La Jolla, CA 92093, United States.

出版信息

Neuroscience. 2015 Dec 3;310:549-60. doi: 10.1016/j.neuroscience.2015.08.068. Epub 2015 Sep 2.

DOI:10.1016/j.neuroscience.2015.08.068
PMID:26341908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4633337/
Abstract

Abnormal accumulation of amyloid β (Aβ), α-synuclein (α-syn), and microtubule-associated protein tau (tau) have been implicated in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and Pick's disease (PiD). The mechanisms through which aggregated versions of α-syn, Aβ, and tau may lead to neurodegeneration are not entirely clear, however, there is emerging evidence that neuronal calcium dysregulation is at play. Two-photon microscopy is a powerful tool that can be used to measure in vivo alterations of calcium transients using animal models of neurodegeneration, and when coupled with statistical methods to characterize functional signals, can reveal features that identify and discern between distinct mouse types. We studied four mouse models of neurodegenerative diseases, wild-type (WT) α-syn, E57K α-syn, amyloid precursor protein (APP), and triple-repeat (3R)-Tau and Non-transgenic (tg) littermates using two-photon microscopy. We found that for calcium transients, simple measures such as area under the curve (AUC) and peak width in the 1-Hz whisker pad stimulation paradigm, were significantly increased for WT α-syn, E57K α-syn and APP mice across all cortical depths compared to Non-tg mice. A similar result was found in the 3-Hz paradigm in E57K α-syn mice. Spontaneous calcium transient AUC was significantly higher in WT α-syn mice and lower for APP and 3R Tau mice at 150-μm depth. Going beyond simple measure differences such as group means for AUC, signal peak width, and spontaneous calcium activity counts, we built statistical classifiers to characterize neuronal calcium signals to identify and discern, with quantified measures of confidence, all mouse types. We tested our classifier with FK506, which regulates mitochondrial calcium and found that this drug modulated the WT α-syn calcium transients to such an extent that the classifier easily identified the calcium transients as belonging to Non-tg mice. The coupling of two-photon microscopy data and statistical classifiers serves to effectively create a bioassay where the number of animals and scientific resources can be reduced without compromising the results of the experiment.

摘要

淀粉样β蛋白(Aβ)、α-突触核蛋白(α-syn)和微管相关蛋白tau(tau)的异常积累与包括阿尔茨海默病(AD)、帕金森病(PD)和皮克病(PiD)在内的神经退行性疾病有关。然而,α-syn、Aβ和tau的聚集形式可能导致神经退行性变的机制尚不完全清楚,不过,越来越多的证据表明神经元钙调节异常在其中起作用。双光子显微镜是一种强大的工具,可用于使用神经退行性疾病动物模型测量体内钙瞬变的变化,并且当与统计方法相结合以表征功能信号时,可以揭示识别和区分不同小鼠类型的特征。我们使用双光子显微镜研究了四种神经退行性疾病小鼠模型,野生型(WT)α-syn、E57K α-syn、淀粉样前体蛋白(APP)和三重复(3R)-Tau以及非转基因(tg)同窝小鼠。我们发现,对于钙瞬变,在1-Hz触须垫刺激范式下,与非tg小鼠相比,WT α-syn、E57K α-syn和APP小鼠在所有皮质深度下,诸如曲线下面积(AUC)和峰值宽度等简单测量值均显著增加。在E57K α-syn小鼠的3-Hz范式中也发现了类似结果。在150-μm深度处,WT α-syn小鼠的自发钙瞬变AUC显著更高,而APP和3R Tau小鼠则更低。除了诸如AUC的组均值、信号峰值宽度和自发钙活性计数等简单测量差异之外,我们构建了统计分类器来表征神经元钙信号,以便通过量化的置信度测量来识别和区分所有小鼠类型。我们用调节线粒体钙的FK506测试了我们的分类器,发现这种药物对WT α-syn钙瞬变的调节程度使得分类器能够轻松地将钙瞬变识别为属于非tg小鼠。双光子显微镜数据与统计分类器的结合有效地创建了一种生物测定方法,在不影响实验结果的情况下,可以减少动物数量和科学资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/29bf5207cbd4/nihms730602f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/0332f5de49d4/nihms730602f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/71867b20ee48/nihms730602f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/91b9ca8c3345/nihms730602f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/1d63e53952c7/nihms730602f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/78488a97a02b/nihms730602f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/71e3baf62ad1/nihms730602f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/4d949cf7cfe6/nihms730602f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/29bf5207cbd4/nihms730602f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/0332f5de49d4/nihms730602f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/71867b20ee48/nihms730602f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/91b9ca8c3345/nihms730602f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/1d63e53952c7/nihms730602f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/78488a97a02b/nihms730602f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/71e3baf62ad1/nihms730602f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/4d949cf7cfe6/nihms730602f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f781/4633337/29bf5207cbd4/nihms730602f8.jpg